BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2537 related articles for article (PubMed ID: 14674398)

  • 1. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceuticals: Medicare Modernization Act--2005. End of Year Issue Brief.
    Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-21. PubMed ID: 16710928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare and state health care programs; fraud and abuse: OIG civil money penalties under the Medicare prescription drug discount card program. Interim final rule with comment period.
    Office of Inspector General (OIG), HHS
    Fed Regist; 2004 May; 69(97):28842-6. PubMed ID: 15151115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
    Thomas CP; Sussman J; ;
    Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicare program; establishment of the Medicare advantage program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4587-741. PubMed ID: 15678604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)/TRICARE; partial implementation of Pharmacy Benefits Program; implementation of National Defense Authorization Act Medical Benefits for fiscal year 2001. Office of the Secretary, DoD. Interim final rule.
    Fed Regist; 2001 Feb; 66(28):9651-8. PubMed ID: 11503862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare and state health care programs; fraud and abuse: OIG civil money penalties under the Medicare prescription drug discount card program. Final rule.
    Office of Inspector General (OIG), HHS
    Fed Regist; 2004 Dec; 69(239):74451-3. PubMed ID: 15597491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare Program; revisions to the Medicare Advantage and Prescription Drug Benefit programs. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Sep; 73(182):54225-54. PubMed ID: 18985953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance among pharmacies in California with a prescription-drug discount program for Medicare beneficiaries.
    Lewis JH; Schonlau M; Muñoz JA; Asch SM; Rosen MR; Yang H; Escarce JJ
    N Engl J Med; 2002 Mar; 346(11):830-5. PubMed ID: 11893795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amendments to regulations regarding eligibility for a Medicare prescription drug subsidy. Interim final rule with request for comments.
    Social Security Administration
    Fed Regist; 2010 Dec; 75(249):81843-6. PubMed ID: 21261125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How beneficiaries fare under the new Medicare drug bill.
    Moon M
    Issue Brief (Commonw Fund); 2004 Jun; (730):1-16. PubMed ID: 15176395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
    Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N
    Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare program; Medicare prescription drug discount card; revision of marketing rules for endorsed drug card sponsors. Final rule.
    Centers for Medicare & Medicaid Services, HHS
    Fed Regist; 2005 Sep; 70(169):52019-23. PubMed ID: 16138430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare premium buy-in programs: results of SSA demonstration projects.
    Nadel M; Alecxih L; Parent R; Sears J
    Soc Secur Bull; 2000; 63(3):26-33. PubMed ID: 11439703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare program; Medicare Advantage and prescription drug benefit programs: negotiated pricing and remaining revisions. Final rule with comment period.
    Fed Regist; 2009 Jan; 74(7):1493-549. PubMed ID: 19143114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons for Medicare Part D in the hemodialysis community.
    Nayeem AI; Chertow GM
    BMC Nephrol; 2006 Jul; 7():11. PubMed ID: 16824211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare Part D subsidies. Final rules.
    Social Security Administration (SSA)
    Fed Regist; 2005 Dec; 70(250):77663-85. PubMed ID: 16392171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Medicare-approved prescription drug discount card.
    James JS
    AIDS Treat News; 2004 May; (401):2-6. PubMed ID: 15241856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 127.